title: [Acute myocardial infarction mortality in Chile: thrombolysis or angioplasty].
abstract: During recent decades, acute myocardial infarction short-term mortality has decreased to one digit levels, in the United States. Data from Chilean registries give figures around 11% for patients receiving thrombolysis, and 5 to 6 % for patients treated with angioplasty. The decrease in mortality in Chile is related to the implementation of the AUGE program at a national level, initiative than gives patients the opportunity to receive at least thrombolytic therapy as well as a standardized and rapid diagnosis and treatment for this condition. There is a lack of Outcome Research studies in Chile, that would guide public health decisions such as the use of fibrin-specific agents for early presentation and high risk cases, and a rational system providing better access to primary angioplasty.
authors.forename: Fernando
authors.initials: F
authors.lastname: Florenzano U
mesh_terms: D017130:Angioplasty; D002677:Chile / Q000453:epidemiology; D006801:Humans; D009203:Myocardial Infarction / Q000401:mortality* / Q000628:therapy; D009313:National Health Programs / Q000592:standards*; D015912:Thrombolytic Therapy